e.g. Tata motors, Reliance MF, 500570

Kwality Pharmaceuticals Ltd. - Research Center

539997 KPL Group (B) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 26 Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 503.06 370.20 307.17 250.99 456.13
Expenses
Material consumed 258.43 182.49 153.18 110.07 201.07
Manufacturing expenses 26.69 23.37 17.22 12.96 11.06
Personnel expenses 54.04 43.76 32.53 29.90 20.09
Selling expenses 3.25 1.68 0.07 0.17 0.12
Adminstrative expenses 42.42 38.45 37.54 37.61 52.07
Expenses capitalised - - - - -
Cost of sales 384.83 289.75 240.54 190.71 284.41
Operating profit 118.23 80.44 66.63 60.29 171.72
Other recurring income 2.86 1.92 1.83 2.94 3.51
Adjusted PBDIT 121.09 82.36 68.46 63.23 175.24
Financial expenses 10.97 9.88 10.39 6.02 2.92
Depreciation 19.79 18.26 19.51 14.92 10.64
Other write offs - - - - -
Adjusted PBT 90.32 54.23 38.57 42.29 161.67
Tax charges 22.15 14.34 7.48 6.29 41.63
Adjusted PAT 68.18 39.89 31.08 36.00 120.05
Non recurring items -0.69 -0.01 -7.16 -16.86 -
Other non cash adjustments - - - - -
Reported net profit 67.48 39.88 23.92 19.14 120.05
Earnigs before appropriation 313.73 246.18 206.30 182.38 162.83
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 313.73 246.18 206.30 182.38 162.83
Close
Add Kwality Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Kwality Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback